Sarah A. Spinler

4.9k total citations · 2 hit papers
126 papers, 3.2k citations indexed

About

Sarah A. Spinler is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Internal Medicine. According to data from OpenAlex, Sarah A. Spinler has authored 126 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Cardiology and Cardiovascular Medicine, 41 papers in Surgery and 36 papers in Internal Medicine. Recurrent topics in Sarah A. Spinler's work include Acute Myocardial Infarction Research (39 papers), Antiplatelet Therapy and Cardiovascular Diseases (38 papers) and Atrial Fibrillation Management and Outcomes (37 papers). Sarah A. Spinler is often cited by papers focused on Acute Myocardial Infarction Research (39 papers), Antiplatelet Therapy and Cardiovascular Diseases (38 papers) and Atrial Fibrillation Management and Outcomes (37 papers). Sarah A. Spinler collaborates with scholars based in United States, Canada and United Kingdom. Sarah A. Spinler's co-authors include Simon de Denus, Mohammad Ali, Barbara S. Wiggins, Edith A. Nutescu, Carol W. Holtzman, Ty J. Gluckman, Ann K. Wittkowsky, James J. Nawarskas, Andrew M. Peterson and Thomas L. Ortel and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Sarah A. Spinler

121 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2017 ACC Expert Consensus Decision Pathway for Periprocedural Management of Anticoagulation in Patients With Nonvalvular Atrial Fibrillation

2017 255 citations Sarah A. Spinler et al. Journal of the American College of Cardiology profile →
Management of Patients at Risk for and With Left Ventricular Thrombus: A Scientific Statement From the American Heart Association

2022 132 citations Sarah A. Spinler et al. profile →

Peers

Countries citing papers authored by Sarah A. Spinler

Since Specialization

Citations

This map shows the geographic impact of Sarah A. Spinler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah A. Spinler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah A. Spinler more than expected).

Fields of papers citing papers by Sarah A. Spinler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah A. Spinler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah A. Spinler. The network helps show where Sarah A. Spinler may publish in the future.

Co-authorship network of co-authors of Sarah A. Spinler

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah A. Spinler. A scholar is included among the top collaborators of Sarah A. Spinler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah A. Spinler. Sarah A. Spinler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of Remdesivir on Heart Rate and Bradycardia Incidence Among Hospitalized Adults With COVID-19 2025 ·Annals of Pharmacotherapy ·Wesley D. Kufel, (unknown), Robert W. Seabury, (unknown), Stephen J. Thomas, Sarah A. Spinler, Jeffrey M. Steele	2
2	Evolving Standards: An Examination of NAPLEX Blueprint Changes and Implications for the Academy 2025 ·American Journal of Pharmaceutical Education ·Diana M Sobieraj, (unknown), Aleda M.H. Chen, (unknown), Lisa Lebovitz, Sarah A. Spinler, (unknown)	2
3	Rivaroxaban Versus Apixaban: A Comparison Without a Simple Solution 2024 ·SHILAP Revista de lepidopterología ·Marc Cohen, Alex C. Spyropoulos, Shaun G. Goodman, Sarah A. Spinler, Marc P. Bonaca, (unknown), (unknown), (unknown)	1
4	US Schools of Pharmacy NAPLEX-Preparation Course Similarities and Differences 2023 ·American Journal of Pharmaceutical Education ·Sarah A. Spinler, (unknown), Lisa Lebovitz, Aleda M.H. Chen, Diana M Sobieraj	3
5	Sodium-Glucose Cotransporter 2 Inhibitors Among Heart Failure With Mildly Reduced and Preserved Ejection Fraction 2023 ·Annals of Pharmacotherapy ·Judy W.M. Cheng, (unknown), James S. Kalus, Sarah A. Spinler	5
6	NAPLEX Preparation Program Characteristics and Resources Associated With First-Time Exam Pass Rates 2023 ·American Journal of Pharmaceutical Education ·Diana M Sobieraj, Aleda M.H. Chen, (unknown), Lisa Lebovitz, Sarah A. Spinler, (unknown)	9
7	Implementation of a formal pharmacy residency research certificate program 2021 ·American Journal of Health-System Pharmacy ·William Darko, Robert W. Seabury, Christopher D. Miller, Sarah A. Spinler, (unknown), Lynn Cleary, (unknown), Wesley D. Kufel	8
8	Aspirin for primary prevention of cardiovascular disease: a review of recent literature and updated guideline recommendations 2020 ·Expert Opinion on Pharmacotherapy ·(unknown), (unknown), (unknown), Sarah A. Spinler	8
9	Focused Updates: SGLT2 Inhibitors in Patients With Heart Failure and/or Chronic Kidney Disease 2020 ·Annals of Pharmacotherapy ·Judy W.M. Cheng, (unknown), James S. Kalus, Sarah A. Spinler	0
10	Translating Guidelines Into Practice: Interpreting the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk 2017 ·Annals of Pharmacotherapy ·(unknown), (unknown), Sarah A. Spinler	2
11	Pharmacology of anticoagulants used in the treatment of venous thromboembolism 2016 ·Journal of Thrombosis and Thrombolysis ·Edith A. Nutescu, Allison Burnett, John Fanikos, Sarah A. Spinler, Ann K. Wittkowsky	99
12	Vorapaxar in Atherosclerotic Disease Management 2015 ·Annals of Pharmacotherapy ·Judy W.M. Cheng, (unknown), Patricia Howard, Jean M. Nappi, Sarah A. Spinler	4
13	Impact of the 2014 Expert Panel Recommendations for Management of High Blood Pressure on Contemporary Cardiovascular Practice 2014 ·Journal of the American College of Cardiology ·William B. Borden, Thomas M. Maddox, Fengming Tang, John S. Rumsfeld, William J. Oetgen, J. Brendan M. Mullen, Sarah A. Spinler, Eric D. Peterson, Frederick A. Masoudi	27
14	Emerging Antiplatelet Therapies in Percutaneous Coronary Intervention: A Focus on Prasugrel 2011 ·Clinical Therapeutics ·Michelle T. Martin, Sarah A. Spinler, Edith A. Nutescu	5
15	Torsades de pointes associated with methadone and voriconazole 2009 ·BMJ Case Reports ·(unknown), Cynthia A. Sanoski, Andrea M. Russo, Joshua M. Cooper, Sarah A. Spinler	5
16	Key Articles and Guidelines in the Management of Acute Coronary Syndromes and in Percutaneous Coronary Intervention: 2007 Update 2007 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Paul P. Dobesh, Sara D. Brouse, William E. Dager, Sarah A. Spinler, Zachary A. Stacy, Barbara S. Wiggins	3
17	Prophylaxis Against Venous Thromboembolism in Acutely Ill Medical Patients: An Observational Study 2006 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·(unknown), Daniel M. Kolansky, Sarah A. Spinler	9
18	Clinical Presentation and Analysis of Risk Factors for Infectious Complications of Implantable Cardioverter‐Defibrillator Implantations at a University Medical Center 1998 ·Clinical Infectious Diseases ·Sarah A. Spinler, James J. Nawarskas, Edward F. Foote, (unknown), (unknown), Francis E. Marchlinski	24
19	Prehospital-Initiated Thrombolysis 1997 ·Annals of Pharmacotherapy ·Sarah A. Spinler, (unknown)	5
20	Low-Osmolality Contrast Media and the Risk of Contrast-Associated Nephrotoxicity 1993 ·Investigative Radiology ·Stanley Goldfarb, Sarah A. Spinler, Jeffrey S. Berns, Michael R. Rudnick	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact